Scarica l'app Stockscreener
83.62
0.55%
0.46
Dopo l'orario di chiusura:
83.62
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$83.16
Aprire:
$83.47
Volume 24 ore:
6.25M
Relative Volume:
0.90
Capitalizzazione di mercato:
$107.17B
Reddito:
$33.20B
Utile/perdita netta:
$4.26B
Rapporto P/E:
25.42
EPS:
3.29
Flusso di cassa netto:
$5.47B
1 W Prestazione:
+0.07%
1M Prestazione:
+2.13%
6M Prestazione:
-4.67%
1 anno Prestazione:
+2.54%
Intervallo 1D:
$83.16
$84.58
Intervallo di 1 settimana:
$81.87
$85.07
Portata 52W:
$75.96
$96.25
Medtronic Plc Stock (MDT) Company Profile
Nome
Medtronic Plc
Settore
Industria
Telefono
01135314381700
Indirizzo
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Confronta MDT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
83.62 | 107.17B | 33.20B | 4.26B | 5.47B | 3.29 |
|
ABT
Abbott Laboratories
|
134.00 | 227.71B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.29 | 152.66B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.46 | 142.93B | 23.22B | 2.86B | 3.58B | 7.40 |
|
EW
Edwards Lifesciences Corp
|
74.63 | 44.04B | 5.54B | 4.18B | 623.10M | 7.00 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-10-10 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | Reiterato | Oppenheimer | Perform |
| 2024-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2024-08-14 | Downgrade | Stifel | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Sell |
| 2023-07-19 | Iniziato | Robert W. Baird | Neutral |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | Downgrade | UBS | Buy → Sell |
| 2023-01-09 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | Downgrade | Citigroup | Buy → Neutral |
| 2022-11-23 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-11-16 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-10-18 | Iniziato | Barclays | Equal Weight |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-08-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | Iniziato | Wolfe Research | Underperform |
| 2022-06-01 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-01-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-06-10 | Ripresa | Cowen | Outperform |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-12-15 | Aggiornamento | Goldman | Sell → Neutral |
| 2020-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | Aggiornamento | Stifel | Hold → Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-05-14 | Downgrade | DZ Bank | Buy → Hold |
| 2020-03-30 | Downgrade | Needham | Strong Buy → Buy |
| 2020-03-25 | Aggiornamento | DZ Bank | Hold → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Sell |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-02 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-06-05 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | Reiterato | Needham | Strong Buy |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2019-01-02 | Downgrade | Citigroup | Buy → Neutral |
| 2018-12-19 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-08-27 | Reiterato | Argus | Buy |
Mostra tutto
Medtronic Plc Borsa (MDT) Ultime notizie
Medtronic (MDT) Rises Yet Lags Behind Market: Some Facts Worth Knowing - Nasdaq
Is Medtronic Stock a Buy Pre-Q4 Earnings? Key Metrics to Watch - Yahoo Finance
Medtronic to announce financial results for its fourth quarter and full fiscal year 2025 - The Globe and Mail
11 Best Medical Device Stocks to Buy Now - Insider Monkey
New survey: 1 in 3 women have not talked to their doctor about heart health, the #1 killer of women - Medtronic
What Are Wall Street Analysts’ Target Price for Medtronic Stock? - MSN
Urology Surgical Instruments Market Top PlayersMedtronic, - openPR.com
Medtronic To Announce Financial Results For Its Fourth Quarter And Full Fiscal Year 2025 - Barchart.com
Intubation Tubes Market Detailed in New Research Report By 2032 | - openPR.com
Medtronic (MDT) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
A Look At The Fair Value Of Medtronic plc (NYSE:MDT) - Yahoo Finance
Medtronic (MDT) Rises Higher Than Market: Key Facts - Yahoo Finance
Medtronic wins FDA approval for defibrillation lead - MedTech Dive
Medtronic Education Program Opens Doors for Employees - Yahoo Finance
Medtronic study backs automated neuromod for overactive bladder - MassDevice
Medtronic and Abbott's game-changing partnership for CGM integration - Today's Medical Developments
4 PFA studies in the spotlight at Heart Rhythm 2025 - MedTech Dive
Earnings Preview: What To Expect From Medtronic’s Report - Nasdaq
Medtronic Gets FDA Nod for Smallest-Diameter, Lumenless Defibrillation Lead - Diagnostic and Interventional Cardiology
Medtronic has positive VenaSeal data - MassDevice
Functional Endoscopic Sinus Surgery Market Key Players - openPR.com
Medtronic submits Hugo soft tissue robot for FDA approval - MedTech Dive
Medtronic inks new distro agreement for Retia Medical Argos cardiac output monitor - MassDevice
The Zacks Analyst Blog Highlights Abbott Laboratories, Boston Scientific and Medtronic - Zacks Investment Research
Medtronic Trial for Robotic-Assisted Surgery System Meets Safety, Effectiveness Primary Endpoints - marketscreener.com
Medtronic’s defibrillation lead gains FDA approval for use in right ventricle - Yahoo Finance
Medtronic Files for FDA Submission for the Hugo Robotic System - Medical Device and Diagnostic industry
Medtronic Affera™ pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients - BioSpace
Smoke Evacuation System Market to Garner $196.4 Million by 2027 | - openPR.com
Medtronic receives US FDA approval for smallest-diameter, lumenless defibrillation lead, the OmniaSecure lead - Pharmabiz.com
Medtronic (MDT) Showcases Positive AFib Treatment Results at Key Medical Conference | MDT Stock News - GuruFocus
Medtronic (MDT) Reveals Promising AFib Treatment Outcomes with S - GuruFocus
Medtronic reports more positive outcomes with Affera PFA tech - MassDevice
Medtronic Affera pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients - Investing News Network
Medtronic PLC Says Sphere-360 Study Shows 88% Freedom From Arrhythmia Recurrence - marketscreener.com
Medtronic submits Hugo surgical robot to FDA, meets trial endpoints - MassDevice
Medtronic (MDT) Seeks FDA Approval for Hugo Robotic Surgery Syst - GuruFocus
Medtronic seeks FDA nod for Hugo robotic surgery system (MDT) - Seeking Alpha
2 Outstanding Dividend Stocks to Buy and Hold For 20 Years - The Motley Fool
Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery systemApr 26, 2025 - Medtronic
Medtronic (NYSE:MDT) Secures FDA Approval For Innovative OmniaSecure Defibrillation Lead - Yahoo Finance
Medtronic wins FDA nod for world’s smallest defibrillation lead - MassDevice
Medtronic (MDT) Gains FDA Approval for Advanced Defibrillation L - GuruFocus
Medtronic receives FDA approval for smallest-diameter, lumenless defibrillation lead, the OmniaSecure™ lead and announces investigational clinical study results - Medtronic
Press Release Distribution & PR Platform - ACCESS Newswire
Medtronic Plc Azioni (MDT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.42%
2.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):